No diagnosis yet
Start with phenotype and records; do not let an uncertain gene result replace clinical evaluation.
INTERNATIONAL PATIENT DECISION GUIDE
Pediatric rare disease: understand the next step
A family pathway for defining the child’s condition, gathering records, finding the correct specialist team, checking research opportunities and avoiding unsafe travel delays.
01
Where should I start?
Choose the situation closest to yours and take the corresponding question to the responsible medical team.
A genetic variant was found
Confirm its classification, inheritance and whether it explains the child’s findings with a qualified genetics team.
The condition is worsening
Stabilize urgent breathing, feeding, seizure, metabolic or infection risks locally before travel planning.
No approved treatment
Review supportive care, natural-history studies, expanded-access rules and registered trials without assuming experimental treatment will help.
Seeking an overseas center
Ask for remote multidisciplinary review, exact required records, language support, cost boundaries and a return-home care plan.
02
What must be confirmed?
Treatment cannot be selected safely from the disease name alone.
- The child’s current working diagnosis and unresolved alternatives
- Symptoms, development and a dated clinical timeline
- Original imaging, laboratory, pathology or genetic reports
- Variant interpretation and family testing when relevant
- Current medicines, nutrition, devices, urgent risks and care team
Urgent safety: Breathing difficulty, prolonged seizure, severe dehydration, altered consciousness, acute weakness or a known emergency plan trigger requires immediate local care.
03
Main treatment categories
The appropriate option and sequence depend on the exact subtype, disease setting, previous treatment, organ function and patient goals.
Condition-specific supportive and preventive care
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
Rehabilitation, nutrition, respiratory or seizure support as appropriate
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
Approved disease-modifying treatment when available
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
Surgery or procedures for defined complications
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
Genetic and family counselling
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
Natural-history studies and clinical trials
Ask what evidence supports this option for the exact diagnosis, what alternatives exist, what monitoring is required and what happens if it does not work.
04
Are there still opportunities?
A safe review includes standard next-line treatment, second opinion, registered trials, symptom support and urgent care—not experimental treatment alone.
Review in this order
- Confirm diagnosis and current disease status.
- Check whether a standard treatment remains.
- Request a disease-specialist second opinion.
- Search registered trials using the exact subtype and eligibility.
- Maintain symptom and supportive care throughout.
Do not assume
- A matching drug name means eligibility.
- A hospital listing proves current international acceptance.
- A trial guarantees benefit or free treatment.
- Travel is safer than timely local treatment.
05
Before considering care in China
Request official pre-travel review before booking or interrupting treatment.
Prepare original reports, images, pathology or laboratory files, treatment history and current medicines.
Ask why the hospital or specialist is relevant to the exact subtype and current treatment decision.
Confirm current international-patient service, supported language and a secure submission route.
Request the expected review process, consultation fees, deposits, exclusions and what may change after reassessment.
Confirm visa documents, fitness to travel and which local treatment must continue.
Require a written summary, monitoring plan, medicine list, warning signs and responsible contact.
Current verified resource pathwayThe lung-cancer guide currently contains the most developed source-linked China resource directory. Disease-specific hospitals and specialists for this guide remain under verification.
See the verified contact methodSources and review status
Source-linked editorial draft. Named medical and English-language review remains pending; noindex remains active.